TY - JOUR
AU - Bengt, Lindholm
AB - Nephrology Dialysis Transplantation 30 (Supplement 3): iii257–iii275, 2015 doi:10.1093/ndt/gfv180.11 index (ρ=-0.36; P<0.001). Median S100A12 at baseline was higher in 23 non-survivors DIALYSIS. PERITONEAL DIALYSIS - 1 (36 [11-62] ng/ml, P<0.05) than in 59 survivors who remained on PD (23 [16-31] ng/ ml) or underwent renal transplantation (29 [23-54] ng/ml), and the highest tertile of S100A12 associated with increased mortality risk, see figure. In HD patients we found similar findings. In contrast, sRAGE was not associated with mortality in PD patients. FP559 ELEVATED CIRCULATING S100A12 ASSOCIATES WITH Peripheral vascular disease or cerebrovascular disease (PCVD) was present in 28% of VASCULAR DISEASE AND CLINICAL OUTCOME IN the PD patients. Presence of PCVD associated with history of CVD, lower s-albumin, PERITONEAL DIALYSIS PATIENTS higher IL-6 and higher S100A12. Multivariate logistic regression analysis showed that 1,2 2 3 PCVD associated mainly with high S100A12 (Odds ratio; 3.52, p=0.04). Naohito Isoyama , Anna Machowska , Abdul Rashid Qureshi , 4,2 2 2 2 Conclusions: Plasma S100A12 and sRAGE, and the ratio S100A12/sRAGE, are Tae Yamamoto , Björn Anderstam , Olof Heimbürger , Peter Barany , 2 5 markedly elevated in PD patients. sRAGE was inversely related to body mass indices Peter Stenvinkel and Lindholm 
TI - FP559ELEVATED CIRCULATING S100A12 ASSOCIATES WITH VASCULAR DISEASE AND CLINICAL OUTCOME IN PERITONEAL DIALYSIS PATIENTS
JO - Nephrology Dialysis Transplantation
DO - 10.1093/ndt/gfv180.11
DA - 2015-05-21
UR - https://www.deepdyve.com/lp/oxford-university-press/fp559elevated-circulating-s100a12-associates-with-vascular-disease-and-pQy45hZ0eV
SP - iii261
EP - iii261
VL - 30
IS - suppl_3
DP - DeepDyve
ER -